First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - UK ZHENSHI GROUP BIOLOGICAL TECHNOLOGY LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: UK ZHENSHI GROUP BIOLOGICAL TECHNOLOGY LTD, RM101, MAPLE HOUSE 118 HIGH STREET, PURLEY, LONDON, ENGLAND, CR8 2AD. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The company was incorporated on 28 June 2017.

The accounts next due date is 28 March 2019. There are no mortgages.

The above was based on public record information as at 29 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 10840982
Date Incorporated: 28 June 2017
Date Latest Accounts: Unknown
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 10840982
Annual Return: Unknown
Registered Office: RM101, MAPLE HOUSE 118 HIGH STREET, PURLEY, LONDON, ENGLAND, CR8 2AD
SIC Code and Operations: 99999
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

UK ZHENSHI GROUP BIOLOGICAL TECHNOLOGY LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 8 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09687290 UK ZHI BO INTERNATIONAL FINANCIAL GROUP CO., LTD Active - Proposal to Strike off
15714653 UK ZHI BO LIMITED Active
10454902 UK ZHIERHUI CROP SCIENCE LIMITED Active
11961153 UK ZHIRONGCH LIMITED Active
12454978 UK ZHONGGUO CONSULTING LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd